University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.
Computational Precision Health, University of California Berkeley and University of California San Francisco, Berkeley, California, USA.
Lupus Sci Med. 2024 Mar 4;11(1):e001140. doi: 10.1136/lupus-2023-001140.
Artificial intelligence and machine learning applications are emerging as transformative technologies in medicine. With greater access to a diverse range of big datasets, researchers are turning to these powerful techniques for data analysis. Machine learning can reveal patterns and interactions between variables in large and complex datasets more accurately and efficiently than traditional statistical methods. Machine learning approaches open new possibilities for studying SLE, a multifactorial, highly heterogeneous and complex disease. Here, we discuss how machine learning methods are rapidly being integrated into the field of SLE research. Recent reports have focused on building prediction models and/or identifying novel biomarkers using both supervised and unsupervised techniques for understanding disease pathogenesis, early diagnosis and prognosis of disease. In this review, we will provide an overview of machine learning techniques to discuss current gaps, challenges and opportunities for SLE studies. External validation of most prediction models is still needed before clinical adoption. Utilisation of deep learning models, access to alternative sources of health data and increased awareness of the ethics, governance and regulations surrounding the use of artificial intelligence in medicine will help propel this exciting field forward.
人工智能和机器学习应用正在成为医学领域的变革性技术。随着对更多种类大数据集的访问,研究人员开始转向这些强大的技术进行数据分析。与传统的统计方法相比,机器学习可以更准确、更有效地揭示大型复杂数据集中变量之间的模式和相互作用。机器学习方法为研究 SLE 这种多因素、高度异质和复杂的疾病开辟了新的可能性。在这里,我们讨论了机器学习方法如何迅速融入 SLE 研究领域。最近的报告侧重于使用监督和无监督技术构建预测模型和/或识别新型生物标志物,以了解疾病发病机制、早期诊断和疾病预后。在这篇综述中,我们将介绍机器学习技术,讨论 SLE 研究的当前差距、挑战和机遇。在临床采用之前,大多数预测模型仍需要进行外部验证。利用深度学习模型、获得替代健康数据来源以及提高对人工智能在医学中使用的伦理、治理和法规的认识,将有助于推动这一令人兴奋的领域向前发展。